Coles is gone, if anyone here didn't know. From today's NPS quarterly PR:
>>Earlier this week, NPS announced the appointment of N. Anthony Coles, M.D., M.P.H., as president and chief operating officer, a new position. Dr. Coles was also appointed to the NPS Board of Directors. He joins NPS from Vertex Pharmaceuticals where he was senior vice president of commercial operations and previously had responsibility for global corporate and business development. Before joining Vertex, Dr. Coles was senior vice president of strategy and policy and senior vice president of marketing and medical affairs, neuroscience/infectious diseases/dermatology at Bristol-Myers Squibb, where he also held senior positions in cardiovascular franchise management and sales. He began his business career at Merck in 1992, where he was responsible for strategic marketing initiatives to managed care companies and hospitals and had operational responsibility for a portfolio of cardiovascular drugs. Dr. Coles will report to Hunter Jackson, Ph.D., whom he will succeed as chief executive officer in approximately six months when Dr. Jackson plans to step down from that position but remain a director of the company. The company believes Dr. Coles's experiences launching new drugs and managing large pharmaceutical organizations will be invaluable as NPS prepares to launch PREOS®, seeks new products for commercial sale, and continues to develop its product pipeline. Dr. Coles will participate in the company's third quarter financial results conference today at 10:00 a.m. EST.<<
Cheers, Tuck |
